Jay Blackman and Safia Samee Ali
  As the new coronavirus continues to envelop much of the globe, a lab outside New York City is racing to find a antibody treatment that could temporarily protect from the illness â€” or even treat it.
  The biotech company Regeneron is in early development of a treatment that could guard against catching the coronavirus for several months using antibodies from mice that have been genetically modified with immune systems to mimic those of humans.
  "We are optimistic, because we've done this approach to treat many human diseases," CEO Leonard Schleifer said.
  Read the full story here. 
 